Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease
- 10 March 2008
- journal article
- research article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 30 (3), 312-322
- https://doi.org/10.1016/j.nbd.2008.01.015
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- The small-animal radiation research platform (SARRP): dosimetry of a focused lens systemPhysics in Medicine & Biology, 2007
- Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington’s diseaseProceedings of the National Academy of Sciences, 2006
- Abnormalities of Neurogenesis in the R6/2 Mouse Model of Huntington's Disease Are Attributable to theIn VivoMicroenvironmentJournal of Neuroscience, 2005
- Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease miceNeurobiology of Disease, 2005
- Brain-Derived Neurotrophic Factor Regulates the Onset and Severity of Motor Dysfunction Associated with Enkephalinergic Neuronal Degeneration in Huntington's DiseaseJournal of Neuroscience, 2004
- Protein aggregation and neurodegenerative diseaseNature Medicine, 2004
- AAV-Mediated gene delivery of BDNF or GDNF is neuroprotective in a model of huntington diseaseMolecular Therapy, 2004
- Intravenous Brain-Derived Neurotrophic Factor Reduces Infarct Size and Counterregulates Bax and Bcl-2 Expression After Temporary Focal Cerebral IschemiaStroke, 2000
- Brain-Derived Neurotrophic Factor-Mediated Protection of Striatal Neurons in an Excitotoxic Rat Model of Huntington's Disease, as Demonstrated by Adenoviral Gene TransferHuman Gene Therapy, 1999
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997